Plješa, Steva

Link to this page

Authority KeyName Variants
e46c0803-0e44-428e-91e1-08ebfcb616fe
  • Plješa, Steva (5)
Projects

Author's Bibliography

Glutathione S-transferase A1, M1, P1 and T1 null or low-activity genotypes are associated with enhanced oxidative damage among haemodialysis patients

Šuvakov, Sonja; Damjanović, Tatjana; Stefanović, Aleksandra; Pekmezović, Tatjana; Savić-Radojević, Ana; Pljesa-Ercegovac, Marija; Matić, Marija; Đukić, Tatjana; Corić, Vesna; Jakovljević, Jovana; Ivanišević, Jasmina; Plješa, Steva; Jelić-Ivanović, Zorana; Mimić-Oka, Jasmina; Dimković, Nada; Simić, Tatjana

(Oxford Univ Press, Oxford, 2013)

TY  - JOUR
AU  - Šuvakov, Sonja
AU  - Damjanović, Tatjana
AU  - Stefanović, Aleksandra
AU  - Pekmezović, Tatjana
AU  - Savić-Radojević, Ana
AU  - Pljesa-Ercegovac, Marija
AU  - Matić, Marija
AU  - Đukić, Tatjana
AU  - Corić, Vesna
AU  - Jakovljević, Jovana
AU  - Ivanišević, Jasmina
AU  - Plješa, Steva
AU  - Jelić-Ivanović, Zorana
AU  - Mimić-Oka, Jasmina
AU  - Dimković, Nada
AU  - Simić, Tatjana
PY  - 2013
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1949
AB  - Background. Increased oxidative stress is a hallmark of end-stage renal disease (ESRD). Glutathione S-transferases (GST) are involved in the detoxification of xenobiotics and protection of oxidative damage. We hypothesized that genetic polymorphism in antioxidant enzymes GSTA1, GSTM1, GSTP1 and GSTT1 is more frequent in ESRD and modulates the degree of oxidative stress in these patients. Methods. GSTA1, GSTM1, GSTP1 and GSTT1 genotypes were determined in 199 ESRD patients and 199 age- and gender-matched controls. Markers of protein and lipid oxidative damage [thiol groups, carbonyl groups, advanced oxidative protein products, nitrotyrosine, malondialdehyde (MDA) and MDA adducts], together with total oxidant status and pro-oxidant antioxidant balance were determined. Results. Individual GST polymorphisms influence vulnerability to both protein and lipid oxidation, with GSTM1-null gene variant having the most pronounced effect. Furthermore, a strong combined effect of null/low-activity GSTM1, GSM, GSTA1 and GSTP1 genotypes in terms of susceptibility towards oxidative and carbonyl stress was found in ESRD patients. When patients were stratified according to GSTM1 and GSTT1, the highest oxidant damage was noted in those with the GSTM1-null/GSTT1-null genotype. The observed effect was even stronger in patients with the third low-activity GSTP1 or GSTA1 genotype. Finally, the level of oxidative and carbonyl stress was most pronounced in the subgroup of patients with all four null or low-activity GSTM1, GSTT1, GSTP1 and GSTA1 genotypes. Conclusions. According to the GST genotype, ESRD patients may be stratified in terms of the level of oxidative and carbonyl stress that might influence cardiovascular prognosis, but could also improve efforts towards individualization of antioxidant treatment.
PB  - Oxford Univ Press, Oxford
T2  - Nephrology Dialysis Transplantation
T1  - Glutathione S-transferase A1, M1, P1 and T1 null or low-activity genotypes are associated with enhanced oxidative damage among haemodialysis patients
VL  - 28
IS  - 1
SP  - 202
EP  - 212
DO  - 10.1093/ndt/gfs369
ER  - 
@article{
author = "Šuvakov, Sonja and Damjanović, Tatjana and Stefanović, Aleksandra and Pekmezović, Tatjana and Savić-Radojević, Ana and Pljesa-Ercegovac, Marija and Matić, Marija and Đukić, Tatjana and Corić, Vesna and Jakovljević, Jovana and Ivanišević, Jasmina and Plješa, Steva and Jelić-Ivanović, Zorana and Mimić-Oka, Jasmina and Dimković, Nada and Simić, Tatjana",
year = "2013",
abstract = "Background. Increased oxidative stress is a hallmark of end-stage renal disease (ESRD). Glutathione S-transferases (GST) are involved in the detoxification of xenobiotics and protection of oxidative damage. We hypothesized that genetic polymorphism in antioxidant enzymes GSTA1, GSTM1, GSTP1 and GSTT1 is more frequent in ESRD and modulates the degree of oxidative stress in these patients. Methods. GSTA1, GSTM1, GSTP1 and GSTT1 genotypes were determined in 199 ESRD patients and 199 age- and gender-matched controls. Markers of protein and lipid oxidative damage [thiol groups, carbonyl groups, advanced oxidative protein products, nitrotyrosine, malondialdehyde (MDA) and MDA adducts], together with total oxidant status and pro-oxidant antioxidant balance were determined. Results. Individual GST polymorphisms influence vulnerability to both protein and lipid oxidation, with GSTM1-null gene variant having the most pronounced effect. Furthermore, a strong combined effect of null/low-activity GSTM1, GSM, GSTA1 and GSTP1 genotypes in terms of susceptibility towards oxidative and carbonyl stress was found in ESRD patients. When patients were stratified according to GSTM1 and GSTT1, the highest oxidant damage was noted in those with the GSTM1-null/GSTT1-null genotype. The observed effect was even stronger in patients with the third low-activity GSTP1 or GSTA1 genotype. Finally, the level of oxidative and carbonyl stress was most pronounced in the subgroup of patients with all four null or low-activity GSTM1, GSTT1, GSTP1 and GSTA1 genotypes. Conclusions. According to the GST genotype, ESRD patients may be stratified in terms of the level of oxidative and carbonyl stress that might influence cardiovascular prognosis, but could also improve efforts towards individualization of antioxidant treatment.",
publisher = "Oxford Univ Press, Oxford",
journal = "Nephrology Dialysis Transplantation",
title = "Glutathione S-transferase A1, M1, P1 and T1 null or low-activity genotypes are associated with enhanced oxidative damage among haemodialysis patients",
volume = "28",
number = "1",
pages = "202-212",
doi = "10.1093/ndt/gfs369"
}
Šuvakov, S., Damjanović, T., Stefanović, A., Pekmezović, T., Savić-Radojević, A., Pljesa-Ercegovac, M., Matić, M., Đukić, T., Corić, V., Jakovljević, J., Ivanišević, J., Plješa, S., Jelić-Ivanović, Z., Mimić-Oka, J., Dimković, N.,& Simić, T.. (2013). Glutathione S-transferase A1, M1, P1 and T1 null or low-activity genotypes are associated with enhanced oxidative damage among haemodialysis patients. in Nephrology Dialysis Transplantation
Oxford Univ Press, Oxford., 28(1), 202-212.
https://doi.org/10.1093/ndt/gfs369
Šuvakov S, Damjanović T, Stefanović A, Pekmezović T, Savić-Radojević A, Pljesa-Ercegovac M, Matić M, Đukić T, Corić V, Jakovljević J, Ivanišević J, Plješa S, Jelić-Ivanović Z, Mimić-Oka J, Dimković N, Simić T. Glutathione S-transferase A1, M1, P1 and T1 null or low-activity genotypes are associated with enhanced oxidative damage among haemodialysis patients. in Nephrology Dialysis Transplantation. 2013;28(1):202-212.
doi:10.1093/ndt/gfs369 .
Šuvakov, Sonja, Damjanović, Tatjana, Stefanović, Aleksandra, Pekmezović, Tatjana, Savić-Radojević, Ana, Pljesa-Ercegovac, Marija, Matić, Marija, Đukić, Tatjana, Corić, Vesna, Jakovljević, Jovana, Ivanišević, Jasmina, Plješa, Steva, Jelić-Ivanović, Zorana, Mimić-Oka, Jasmina, Dimković, Nada, Simić, Tatjana, "Glutathione S-transferase A1, M1, P1 and T1 null or low-activity genotypes are associated with enhanced oxidative damage among haemodialysis patients" in Nephrology Dialysis Transplantation, 28, no. 1 (2013):202-212,
https://doi.org/10.1093/ndt/gfs369 . .
10
52
47
56

Effect of n-3 fatty acids on nutritional status and inflammatory markers in haemodialysis patients

Peruničić-Peković, Gordana; Rasić, Zorica; Plješa, Steva; Šobajić, Slađana; Đuričić, Ivana; Maletić, Radojka; Ristić-Medić, Danijela K.

(Wiley, Hoboken, 2007)

TY  - JOUR
AU  - Peruničić-Peković, Gordana
AU  - Rasić, Zorica
AU  - Plješa, Steva
AU  - Šobajić, Slađana
AU  - Đuričić, Ivana
AU  - Maletić, Radojka
AU  - Ristić-Medić, Danijela K.
PY  - 2007
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/990
AB  - Aims: Nutrition as an aetiological factor participates a great deal in premature atherosclerosis in haemodialysis (HD) patients. The basic mechanisms of end-stage renal disease and premature atherosclerosis are connected with changes in cell functions at the membrane level. We investigated the red cell membrane fatty acids and the effects of fish oil supplements on nutritional status and inflammatory markers in HD patients. Methods: We examined 42 HD patients (mean age 55 +/- 8 years). The control group consisted of 16 healthy subjects of similar age and sex to the tested group. HD patients were administered supplements with 2.4 g of n-3 polyunsaturated fatty acids per day for 2 months. Before and after supplementation, we examined plasma lipids, cell membrane erythrocyte phospholipids content, serum albumin, haemoglobin, interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-alpha). Results: Baseline values in the tested group confirmed the presence of essential fatty acids deficiency. A statistically significant negative correlation between TNF-alpha and eicosapentaenoic acid (EPA) (r=-0.497; P  lt  0.05) and IL-6 and EPA (r=-468; P=0.03) was found in HD patients before supplementation. There was a significant increase in docosahexaenoic acids, high density lipoprotein cholesterol, plasma albumin, haemoglobin levels in HD patients after supplementation (P=0.0001). There was a significant increase in EPA (P=0.01) after treatment, and there was a significant decrease in inflammatory markers (IL-6 and TNF-alpha, P=0.0001) after supplementation in the tested group. Conclusion: A dietary regime with fish oil could be used in dialysis patients to slow down the development of atherosclerosis and improve nutritional parameters.
PB  - Wiley, Hoboken
T2  - Nephrology
T1  - Effect of n-3 fatty acids on nutritional status and inflammatory markers in haemodialysis patients
VL  - 12
IS  - 4
SP  - 331
EP  - 336
DO  - 10.1111/j.1440-1797.2007.00777.x
ER  - 
@article{
author = "Peruničić-Peković, Gordana and Rasić, Zorica and Plješa, Steva and Šobajić, Slađana and Đuričić, Ivana and Maletić, Radojka and Ristić-Medić, Danijela K.",
year = "2007",
abstract = "Aims: Nutrition as an aetiological factor participates a great deal in premature atherosclerosis in haemodialysis (HD) patients. The basic mechanisms of end-stage renal disease and premature atherosclerosis are connected with changes in cell functions at the membrane level. We investigated the red cell membrane fatty acids and the effects of fish oil supplements on nutritional status and inflammatory markers in HD patients. Methods: We examined 42 HD patients (mean age 55 +/- 8 years). The control group consisted of 16 healthy subjects of similar age and sex to the tested group. HD patients were administered supplements with 2.4 g of n-3 polyunsaturated fatty acids per day for 2 months. Before and after supplementation, we examined plasma lipids, cell membrane erythrocyte phospholipids content, serum albumin, haemoglobin, interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-alpha). Results: Baseline values in the tested group confirmed the presence of essential fatty acids deficiency. A statistically significant negative correlation between TNF-alpha and eicosapentaenoic acid (EPA) (r=-0.497; P  lt  0.05) and IL-6 and EPA (r=-468; P=0.03) was found in HD patients before supplementation. There was a significant increase in docosahexaenoic acids, high density lipoprotein cholesterol, plasma albumin, haemoglobin levels in HD patients after supplementation (P=0.0001). There was a significant increase in EPA (P=0.01) after treatment, and there was a significant decrease in inflammatory markers (IL-6 and TNF-alpha, P=0.0001) after supplementation in the tested group. Conclusion: A dietary regime with fish oil could be used in dialysis patients to slow down the development of atherosclerosis and improve nutritional parameters.",
publisher = "Wiley, Hoboken",
journal = "Nephrology",
title = "Effect of n-3 fatty acids on nutritional status and inflammatory markers in haemodialysis patients",
volume = "12",
number = "4",
pages = "331-336",
doi = "10.1111/j.1440-1797.2007.00777.x"
}
Peruničić-Peković, G., Rasić, Z., Plješa, S., Šobajić, S., Đuričić, I., Maletić, R.,& Ristić-Medić, D. K.. (2007). Effect of n-3 fatty acids on nutritional status and inflammatory markers in haemodialysis patients. in Nephrology
Wiley, Hoboken., 12(4), 331-336.
https://doi.org/10.1111/j.1440-1797.2007.00777.x
Peruničić-Peković G, Rasić Z, Plješa S, Šobajić S, Đuričić I, Maletić R, Ristić-Medić DK. Effect of n-3 fatty acids on nutritional status and inflammatory markers in haemodialysis patients. in Nephrology. 2007;12(4):331-336.
doi:10.1111/j.1440-1797.2007.00777.x .
Peruničić-Peković, Gordana, Rasić, Zorica, Plješa, Steva, Šobajić, Slađana, Đuričić, Ivana, Maletić, Radojka, Ristić-Medić, Danijela K., "Effect of n-3 fatty acids on nutritional status and inflammatory markers in haemodialysis patients" in Nephrology, 12, no. 4 (2007):331-336,
https://doi.org/10.1111/j.1440-1797.2007.00777.x . .
57
51
56

Effects of N-3PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients

Rasić-Milutinović, Z.; Perunicić, G.; Plješa, Steva; Gluvić, Z.; Šobajić, Slađana; Đurić, I.; Ristić, D.

(Taylor & Francis Ltd, Abingdon, 2007)

TY  - JOUR
AU  - Rasić-Milutinović, Z.
AU  - Perunicić, G.
AU  - Plješa, Steva
AU  - Gluvić, Z.
AU  - Šobajić, Slađana
AU  - Đurić, I.
AU  - Ristić, D.
PY  - 2007
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/935
AB  - Aims/Hypothesis. It was suggested that polyunsaturated n-3 fatty acids (n-3 PUFAs) could improve insulin sensitivity and have an anti-inflammatory effects in overall population. This study investigates a possible effect of n-3 PUFAs supplementation on the insulin sensitivity and some inflammatory markers; hence, patients with chronic renal failure (CRF) on maintenance hemodialysis (MHD) are presented with insulin resistance. Methods. This study explored the ratio between red blood cells (RBC) phospholipid long chain fatty acids (LC FAs) and components of metabolic syndrome (MeS) in 35 patients (mean age 54.50 +/- 11.99 years) with CRF on MHD. Furthermore, the effects of omega-3 FA eight-week's supplementation (EPA+DHA, 2.4g/d) on the MeS features and inflammatory markers TNF-alpha, IL 6, and hsCRP were examined. Results. Supplementation increased EPA and DHA levels in RBCs (p = 0.009 for EPA and p = 0.002 for DHA). Total n-6 PUFAs: n-3 PUFAs ratio tended to be lower after supplementation (p = 0.31), but not significantly. Data revealed a significant decrease of saturated FAs (SFA) (P = 0.01) as well as total SFA: n-3 PUFAs ratio during the treatment (P = 0.04). The values of serum insulin and calculated IR index-IR HOMA were reduced after supplementation (p = 0.001 for both). There was a significant decrease in the levels of all inflammatory markers (p = 0.01 for TNF alpha, p = 0.001 for IL 6, p = 0.001 for hsCRP, and p = 0.01 for ferritin). In multivariate regression analysis, only the changes in n-6 PUFAs: n-3 PUFAs ratio independently contributed to 40% of the variance in IR HOMA. The impact of changes in PUFAs level in RBCs membrane phospholipid fatty acids on inflammation markers was also registered. The changes in n-6: n-3 PUFAs ratio independently contributed to 19% of the variance in TNF alpha. Conclusion. It was concluded that the EPA and DHA moderate dose administration in the patients with CRF on MHD had a beneficial effect on insulin resistance decrease. The anti-inflammatory effects of the supplemented PUFAs were also presented.
PB  - Taylor & Francis Ltd, Abingdon
T2  - Reproductive Toxicology
T1  - Effects of N-3PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients
VL  - 29
IS  - 3
SP  - 321
EP  - 329
DO  - 10.1080/08860220601184092
ER  - 
@article{
author = "Rasić-Milutinović, Z. and Perunicić, G. and Plješa, Steva and Gluvić, Z. and Šobajić, Slađana and Đurić, I. and Ristić, D.",
year = "2007",
abstract = "Aims/Hypothesis. It was suggested that polyunsaturated n-3 fatty acids (n-3 PUFAs) could improve insulin sensitivity and have an anti-inflammatory effects in overall population. This study investigates a possible effect of n-3 PUFAs supplementation on the insulin sensitivity and some inflammatory markers; hence, patients with chronic renal failure (CRF) on maintenance hemodialysis (MHD) are presented with insulin resistance. Methods. This study explored the ratio between red blood cells (RBC) phospholipid long chain fatty acids (LC FAs) and components of metabolic syndrome (MeS) in 35 patients (mean age 54.50 +/- 11.99 years) with CRF on MHD. Furthermore, the effects of omega-3 FA eight-week's supplementation (EPA+DHA, 2.4g/d) on the MeS features and inflammatory markers TNF-alpha, IL 6, and hsCRP were examined. Results. Supplementation increased EPA and DHA levels in RBCs (p = 0.009 for EPA and p = 0.002 for DHA). Total n-6 PUFAs: n-3 PUFAs ratio tended to be lower after supplementation (p = 0.31), but not significantly. Data revealed a significant decrease of saturated FAs (SFA) (P = 0.01) as well as total SFA: n-3 PUFAs ratio during the treatment (P = 0.04). The values of serum insulin and calculated IR index-IR HOMA were reduced after supplementation (p = 0.001 for both). There was a significant decrease in the levels of all inflammatory markers (p = 0.01 for TNF alpha, p = 0.001 for IL 6, p = 0.001 for hsCRP, and p = 0.01 for ferritin). In multivariate regression analysis, only the changes in n-6 PUFAs: n-3 PUFAs ratio independently contributed to 40% of the variance in IR HOMA. The impact of changes in PUFAs level in RBCs membrane phospholipid fatty acids on inflammation markers was also registered. The changes in n-6: n-3 PUFAs ratio independently contributed to 19% of the variance in TNF alpha. Conclusion. It was concluded that the EPA and DHA moderate dose administration in the patients with CRF on MHD had a beneficial effect on insulin resistance decrease. The anti-inflammatory effects of the supplemented PUFAs were also presented.",
publisher = "Taylor & Francis Ltd, Abingdon",
journal = "Reproductive Toxicology",
title = "Effects of N-3PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients",
volume = "29",
number = "3",
pages = "321-329",
doi = "10.1080/08860220601184092"
}
Rasić-Milutinović, Z., Perunicić, G., Plješa, S., Gluvić, Z., Šobajić, S., Đurić, I.,& Ristić, D.. (2007). Effects of N-3PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients. in Reproductive Toxicology
Taylor & Francis Ltd, Abingdon., 29(3), 321-329.
https://doi.org/10.1080/08860220601184092
Rasić-Milutinović Z, Perunicić G, Plješa S, Gluvić Z, Šobajić S, Đurić I, Ristić D. Effects of N-3PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients. in Reproductive Toxicology. 2007;29(3):321-329.
doi:10.1080/08860220601184092 .
Rasić-Milutinović, Z., Perunicić, G., Plješa, Steva, Gluvić, Z., Šobajić, Slađana, Đurić, I., Ristić, D., "Effects of N-3PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients" in Reproductive Toxicology, 29, no. 3 (2007):321-329,
https://doi.org/10.1080/08860220601184092 . .
80
80
89

The effect of n-3 fatty acids on nutritional status and inflammatory markers in hemodialysis patients

Peruničić-Peković, Gordana; Rasić, Z.; Plješa, Steva; Šobajić, Slađana; Đuričić, Ivana

(Elsevier Ireland Ltd, Clare, 2006)

TY  - CONF
AU  - Peruničić-Peković, Gordana
AU  - Rasić, Z.
AU  - Plješa, Steva
AU  - Šobajić, Slađana
AU  - Đuričić, Ivana
PY  - 2006
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/822
PB  - Elsevier Ireland Ltd, Clare
C3  - Atherosclerosis Supplements
T1  - The effect of n-3 fatty acids on nutritional status and inflammatory markers in hemodialysis patients
VL  - 7
IS  - 3
SP  - 450
EP  - 450
DO  - 10.1016/S1567-5688(06)81821-0
ER  - 
@conference{
author = "Peruničić-Peković, Gordana and Rasić, Z. and Plješa, Steva and Šobajić, Slađana and Đuričić, Ivana",
year = "2006",
publisher = "Elsevier Ireland Ltd, Clare",
journal = "Atherosclerosis Supplements",
title = "The effect of n-3 fatty acids on nutritional status and inflammatory markers in hemodialysis patients",
volume = "7",
number = "3",
pages = "450-450",
doi = "10.1016/S1567-5688(06)81821-0"
}
Peruničić-Peković, G., Rasić, Z., Plješa, S., Šobajić, S.,& Đuričić, I.. (2006). The effect of n-3 fatty acids on nutritional status and inflammatory markers in hemodialysis patients. in Atherosclerosis Supplements
Elsevier Ireland Ltd, Clare., 7(3), 450-450.
https://doi.org/10.1016/S1567-5688(06)81821-0
Peruničić-Peković G, Rasić Z, Plješa S, Šobajić S, Đuričić I. The effect of n-3 fatty acids on nutritional status and inflammatory markers in hemodialysis patients. in Atherosclerosis Supplements. 2006;7(3):450-450.
doi:10.1016/S1567-5688(06)81821-0 .
Peruničić-Peković, Gordana, Rasić, Z., Plješa, Steva, Šobajić, Slađana, Đuričić, Ivana, "The effect of n-3 fatty acids on nutritional status and inflammatory markers in hemodialysis patients" in Atherosclerosis Supplements, 7, no. 3 (2006):450-450,
https://doi.org/10.1016/S1567-5688(06)81821-0 . .

Polyunsaturated fatty acids in cell membranes of erythrocytes, nutritional status and dietary intervention in hemodialysis patients

Peruničić-Peković, Gordana; Rasić, Zorica; Plješa, Steva; Šobajić, Slađana; Đuričić, Ivana

(Oxford Univ Press, Oxford, 2006)

TY  - CONF
AU  - Peruničić-Peković, Gordana
AU  - Rasić, Zorica
AU  - Plješa, Steva
AU  - Šobajić, Slađana
AU  - Đuričić, Ivana
PY  - 2006
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/777
PB  - Oxford Univ Press, Oxford
C3  - Nephrology Dialysis Transplantation
T1  - Polyunsaturated fatty acids in cell membranes of erythrocytes, nutritional status and dietary intervention in hemodialysis patients
VL  - 21
SP  - 458
EP  - 458
UR  - https://hdl.handle.net/21.15107/rcub_farfar_777
ER  - 
@conference{
author = "Peruničić-Peković, Gordana and Rasić, Zorica and Plješa, Steva and Šobajić, Slađana and Đuričić, Ivana",
year = "2006",
publisher = "Oxford Univ Press, Oxford",
journal = "Nephrology Dialysis Transplantation",
title = "Polyunsaturated fatty acids in cell membranes of erythrocytes, nutritional status and dietary intervention in hemodialysis patients",
volume = "21",
pages = "458-458",
url = "https://hdl.handle.net/21.15107/rcub_farfar_777"
}
Peruničić-Peković, G., Rasić, Z., Plješa, S., Šobajić, S.,& Đuričić, I.. (2006). Polyunsaturated fatty acids in cell membranes of erythrocytes, nutritional status and dietary intervention in hemodialysis patients. in Nephrology Dialysis Transplantation
Oxford Univ Press, Oxford., 21, 458-458.
https://hdl.handle.net/21.15107/rcub_farfar_777
Peruničić-Peković G, Rasić Z, Plješa S, Šobajić S, Đuričić I. Polyunsaturated fatty acids in cell membranes of erythrocytes, nutritional status and dietary intervention in hemodialysis patients. in Nephrology Dialysis Transplantation. 2006;21:458-458.
https://hdl.handle.net/21.15107/rcub_farfar_777 .
Peruničić-Peković, Gordana, Rasić, Zorica, Plješa, Steva, Šobajić, Slađana, Đuričić, Ivana, "Polyunsaturated fatty acids in cell membranes of erythrocytes, nutritional status and dietary intervention in hemodialysis patients" in Nephrology Dialysis Transplantation, 21 (2006):458-458,
https://hdl.handle.net/21.15107/rcub_farfar_777 .